Brain

NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China

GUANGZHOU, China, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), an…

3 months ago

Natus seeks FDA 510(k) clearance for its highly anticipated point-of-care EEG solution

MIDDLETON, Wis., Oct. 10, 2024 /PRNewswire/ -- Natus Medical Incorporated announced it has submitted an FDA 510(k) premarket notification to…

3 months ago

CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment

Segment featuring members of the CNS management team and leading Neuro-Oncologist and Key Opinion Leader, Dr. Samuel GoldlustAccess the segment…

3 months ago

Top Young Innovator Announces Dallas-Based Hisham Ahmad as America’s “Top Young Innovator 2024”

DiscoverSTEM Celebrates Innovation with Award-Winning Solutions from Youth Innovators Across the USA and UAE.Dallas, Texas--(Newsfile Corp. - October 9, 2024)…

3 months ago

Nicole Garrett’s Under Pressure Hyperbarics Partners With L.A. Fashion Weekend to Elevate the Health and Wellness Component

Introducing Cutting-Edge Wellness Experiences to the Heart of LA's Fashion SceneLOS ANGELES, CA / ACCESSWIRE / October 9, 2024 /…

3 months ago

Global Health Exhibition to Unveil the World’s Largest Virtual Hospital in Riyadh

Exclusive exhibit will enable attendees to experience simulated patient scenarios and determine treatment and therapy actionsTechnology behind the virtual hospital…

3 months ago

Lexaria’s GLP-1 Human Pilot Study #3 Begins Dosing

DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC / ACCESSWIRE / October 9, 2024…

3 months ago

Gain Therapeutics to Present at Michael J. Fox Foundation’s 16th Annual Parkinson’s Disease Therapeutics Conference

BETHESDA, Md., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology…

3 months ago

BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea

BURLINGTON, Mass. and JERUSALEM, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the…

3 months ago

Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation

SARASOTA, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biopharmaceutical company committed to developing novel…

3 months ago